And it doesn't trigger the hormonal response that drives muscle protein synthesis
"This is not a replacement for trials, but it can move much faster, and that speed matters when a drug goes from niche to mainstream almost overnight." Large Language Models Speed Up Side Effect Detection One major challenge in studying online health discussions has been scale
Lancet Diabetes Endocrinol 5(11):887897
Tirzepatide as monotherapy improved markers of beta-cell function and insulin sensitivity in type 2 diabetes (SURPASS-1)
Sometimes its not the weight loss thats going to improve their outcomes, but the weight loss thats needed to be able to access these more advanced and successful treatments [because of BMI limits in some IVF programs], Boots said
Results Case report A 35-year-old female with GH-secreting pituitary tumors was treated with surgery and medical therapy using the first-generation SSA, octreotide, and the D2 agonist, cabergoline